AVTX — AVALO THERAPEUTICS INC

Ownership history in SUPERSTRING CAPITAL MANAGEMENT LP  ·  2 quarters on record

This page tracks every 13F SEC filing in which SUPERSTRING CAPITAL MANAGEMENT LP reported a position in AVALO THERAPEUTICS INC (AVTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
2.36% (2025 Q3)
Avg. % of fund
1.92%
First filed
2025 Q3
Last filed
2025 Q4
Quarters held
2
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 153,313 -34,767 -18.5% 1.49% $2.8M $18.16
2025 Q3 INITIATED 188,080 — — 2.36% $2.4M $12.71
% of Fund (quarterly)    AVTX price (monthly, adj. close)

Other funds also holding AVTX

As of 2025 Q4 — sorted by position size

Velan Capital Investment Management LP 3Y 2.78% SILVERARC CAPITAL MANAGEMENT, LLC 3Y 1.32% Caligan Partners LP 3Y 1.32% Patient Square Capital LP 3Y 1.21% Affinity Asset Advisors, LLC 3Y 1.09% Seven Fleet Capital Management LP 0.87% BVF INC/IL 3Y 7Y 0.83% Nantahala Capital Management, LLC 3Y 7Y 0.74% GREAT POINT PARTNERS LLC 3Y 7Y 0.73% Commodore Capital LP 3Y 0.58%
← Back to SUPERSTRING CAPITAL MANAGEMENT LP Holdings